Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by Analysts at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of AMPE stock opened at $0.00 on Friday. The company has a market cap of $2,964.00, a P/E ratio of 0.00 and a beta of 3.73. The stock has a 50 day simple moving average of $0.01 and a two-hundred day simple moving average of $0.06. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $7.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.